• Je něco špatně v tomto záznamu ?

Sumoylated NHR-25/NR5A regulates cell fate during C. elegans vulval development

JD. Ward, N. Bojanala, T. Bernal, K. Ashrafi, M. Asahina, KR. Yamamoto,

. 2013 ; 9 (12) : e1003992.

Jazyk angličtina Země Spojené státy americké

Typ dokumentu časopisecké články, Research Support, N.I.H., Extramural, práce podpořená grantem, Research Support, U.S. Gov't, Non-P.H.S.

Perzistentní odkaz   https://www.medvik.cz/link/bmc14074401

Individual metazoan transcription factors (TFs) regulate distinct sets of genes depending on cell type and developmental or physiological context. The precise mechanisms by which regulatory information from ligands, genomic sequence elements, co-factors, and post-translational modifications are integrated by TFs remain challenging questions. Here, we examine how a single regulatory input, sumoylation, differentially modulates the activity of a conserved C. elegans nuclear hormone receptor, NHR-25, in different cell types. Through a combination of yeast two-hybrid analysis and in vitro biochemistry we identified the single C. elegans SUMO (SMO-1) as an NHR-25 interacting protein, and showed that NHR-25 is sumoylated on at least four lysines. Some of the sumoylation acceptor sites are in common with those of the NHR-25 mammalian orthologs SF-1 and LRH-1, demonstrating that sumoylation has been strongly conserved within the NR5A family. We showed that NHR-25 bound canonical SF-1 binding sequences to regulate transcription, and that NHR-25 activity was enhanced in vivo upon loss of sumoylation. Knockdown of smo-1 mimicked NHR-25 overexpression with respect to maintenance of the 3° cell fate in vulval precursor cells (VPCs) during development. Importantly, however, overexpression of unsumoylatable alleles of NHR-25 revealed that NHR-25 sumoylation is critical for maintaining 3° cell fate. Moreover, SUMO also conferred formation of a developmental time-dependent NHR-25 concentration gradient across the VPCs. That is, accumulation of GFP-tagged NHR-25 was uniform across VPCs at the beginning of development, but as cells began dividing, a smo-1-dependent NHR-25 gradient formed with highest levels in 1° fated VPCs, intermediate levels in 2° fated VPCs, and low levels in 3° fated VPCs. We conclude that sumoylation operates at multiple levels to affect NHR-25 activity in a highly coordinated spatial and temporal manner.

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc14074401
003      
CZ-PrNML
005      
20141009120306.0
007      
ta
008      
141006s2013 xxu f 000 0|eng||
009      
AR
024    7_
$a 10.1371/journal.pgen.1003992 $2 doi
035    __
$a (PubMed)24348269
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a xxu
100    1_
$a Ward, Jordan D $u Department of Cellular and Molecular Pharmacology, University of California San Francisco, San Francisco, California, United States of America.
245    10
$a Sumoylated NHR-25/NR5A regulates cell fate during C. elegans vulval development / $c JD. Ward, N. Bojanala, T. Bernal, K. Ashrafi, M. Asahina, KR. Yamamoto,
520    9_
$a Individual metazoan transcription factors (TFs) regulate distinct sets of genes depending on cell type and developmental or physiological context. The precise mechanisms by which regulatory information from ligands, genomic sequence elements, co-factors, and post-translational modifications are integrated by TFs remain challenging questions. Here, we examine how a single regulatory input, sumoylation, differentially modulates the activity of a conserved C. elegans nuclear hormone receptor, NHR-25, in different cell types. Through a combination of yeast two-hybrid analysis and in vitro biochemistry we identified the single C. elegans SUMO (SMO-1) as an NHR-25 interacting protein, and showed that NHR-25 is sumoylated on at least four lysines. Some of the sumoylation acceptor sites are in common with those of the NHR-25 mammalian orthologs SF-1 and LRH-1, demonstrating that sumoylation has been strongly conserved within the NR5A family. We showed that NHR-25 bound canonical SF-1 binding sequences to regulate transcription, and that NHR-25 activity was enhanced in vivo upon loss of sumoylation. Knockdown of smo-1 mimicked NHR-25 overexpression with respect to maintenance of the 3° cell fate in vulval precursor cells (VPCs) during development. Importantly, however, overexpression of unsumoylatable alleles of NHR-25 revealed that NHR-25 sumoylation is critical for maintaining 3° cell fate. Moreover, SUMO also conferred formation of a developmental time-dependent NHR-25 concentration gradient across the VPCs. That is, accumulation of GFP-tagged NHR-25 was uniform across VPCs at the beginning of development, but as cells began dividing, a smo-1-dependent NHR-25 gradient formed with highest levels in 1° fated VPCs, intermediate levels in 2° fated VPCs, and low levels in 3° fated VPCs. We conclude that sumoylation operates at multiple levels to affect NHR-25 activity in a highly coordinated spatial and temporal manner.
650    _2
$a sekvence aminokyselin $7 D000595
650    _2
$a zvířata $7 D000818
650    _2
$a Caenorhabditis elegans $x genetika $x růst a vývoj $7 D017173
650    _2
$a buněčná diferenciace $x genetika $7 D002454
650    _2
$a DNA vazebné proteiny $x biosyntéza $x genetika $7 D004268
650    _2
$a ženské pohlaví $7 D005260
650    _2
$a vývojová regulace genové exprese $7 D018507
650    _2
$a mapy interakcí proteinů $7 D060066
650    _2
$a protein SUMO-1 $x genetika $x metabolismus $7 D025842
650    _2
$a signální transdukce $x genetika $7 D015398
650    12
$a sumoylace $7 D058207
650    _2
$a transkripční faktory $x biosyntéza $x genetika $7 D014157
650    _2
$a vulva $x cytologie $x růst a vývoj $7 D014844
655    _2
$a časopisecké články $7 D016428
655    _2
$a Research Support, N.I.H., Extramural $7 D052061
655    _2
$a práce podpořená grantem $7 D013485
655    _2
$a Research Support, U.S. Gov't, Non-P.H.S. $7 D013486
700    1_
$a Bojanala, Nagagireesh $u Institute of Parasitology, Biology Centre ASCR, Ceske Budejovice, Czech Republic ; University of South Bohemia, Ceske Budejovice, Czech Republic.
700    1_
$a Bernal, Teresita $u Department of Cellular and Molecular Pharmacology, University of California San Francisco, San Francisco, California, United States of America.
700    1_
$a Ashrafi, Kaveh $u Department of Physiology, University of California San Francisco, San Francisco, California, United States of America. $7 gn_A_00009323
700    1_
$a Asahina, Masako $u Department of Cellular and Molecular Pharmacology, University of California San Francisco, San Francisco, California, United States of America ; Institute of Parasitology, Biology Centre ASCR, Ceske Budejovice, Czech Republic ; University of South Bohemia, Ceske Budejovice, Czech Republic. $7 gn_A_00009161
700    1_
$a Yamamoto, Keith R $u Department of Cellular and Molecular Pharmacology, University of California San Francisco, San Francisco, California, United States of America.
773    0_
$w MED00008920 $t PLoS genetics $x 1553-7404 $g Roč. 9, č. 12 (2013), s. e1003992
856    41
$u https://pubmed.ncbi.nlm.nih.gov/24348269 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y a $z 0
990    __
$a 20141006 $b ABA008
991    __
$a 20141009120655 $b ABA008
999    __
$a ok $b bmc $g 1042284 $s 873313
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2013 $b 9 $c 12 $d e1003992 $i 1553-7404 $m PLoS genetics $n PLoS Genet $x MED00008920
LZP    __
$a Pubmed-20141006

Najít záznam

Citační ukazatele

Nahrávání dat ...

    Možnosti archivace